MIAS Pharma Ltd was set up in 2016 to enable Pharma / Bio-Pharma companies to manufacture and import products into the EU / EEA in a compliant manner, at optimal cost, with no significant investment in licence application activities or office / personnel costs.
MIAS Pharma delivers two main solutions:
A licence platform to enable pharmaceutical importation and batch certification (required before each batch of a medicine can be made available in the EU/EEA marketplace)
Qualified Person (QP) services to oversee the release of investigational medicinal product for Clinical Trials and commercial product to the market.
MIAS Pharma can also provide oversight of: